VELTASSA Rx

Select the drug indication to add to your list

VELTASSA

Electrolyte disturbances
Only 4 drugs may be compared at once

Generic Name and Formulations:

Patiromer 8.4g, 16.8g, 25.2g; per pkt; pwd for oral susp.

Company:

Relypsa, Inc.

Select therapeutic use:

Indications for VELTASSA:

Hyperkalemia.

Limitations Of use:

Not for emergency treatment for life-threatening hyperkalemia due to its delayed onset of action.

Adult:

Give at least 3hrs before or 3hrs after other oral medications. Take with food. Initially 8.4g once daily. Adjust dose in 8.4g increments as needed at ≥1-week intervals to obtain desired serum potassium target range; max 25.2g/day.

Children:

Not established.

Warnings/Precautions:

Monitor serum potassium, magnesium. Consider magnesium supplementation if low serum levels develop. Severe constipation, bowel obstruction or impaction, abnormal post-op bowel motility disorders; avoid.

Interactions:

May reduce absorption and efficacy of other oral medications; separate dosing by at least 3hrs.

Pharmacological Class:

Potassium binder.

Adverse Reactions:

Constipation, hypomagnesemia, diarrhea, nausea, abdominal discomfort, flatulence.

Generic Availability:

NO

How Supplied:

Single-use packets (8.4g)—4, 30; (16.8g, 25.2g)—30

VELTASSA 30 packets of 8.4g cartons (Qty:1)

appx. price $903.00